In this randomised, double-blind, placebo-controlled study, adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity received weekly subcutaneous injections of retatrutide at varying doses over 48 weeks
You may also experience reduced cravings, better mobility, and more energy
Your first visit allows you to meet with a physician, discuss your goals, review your health history, and determine whether an HCG-based plan or another medical weight-loss option is more appropriate for you
It can be difficult to tell without a dental exam
L., Dahl, K., Schffer, L., Sensfuss, U., Poulsen, C., Schlein, M., Hansen, A